Sterling Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.06M | Sell |
13,491
-1
| -0% | -$153 | 0.04% | 330 |
|
|
2025
Q4 | $1.86M | Sell |
13,492
-772
| -5% | -$101K | 0.03% | 423 |
|
|
2025
Q3 | $1.83M | Buy |
14,264
+2,760
| +24% | +$337K | 0.03% | 420 |
|
|
2025
Q2 | $1.39M | Buy |
11,504
+1,111
| +11% | +$125K | 0.02% | 515 |
|
|
2025
Q1 | $1.16M | Sell |
10,393
-1,459
| -12% | -$155K | 0.02% | 559 |
|
|
2024
Q4 | $1.15M | Sell |
11,852
-1,358
| -10% | -$145K | 0.02% | 598 |
|
|
2024
Q3 | $1.52M | Buy |
+13,210
| New | +$1.5M | 0.02% | 454 |
|
|
2019
Q3 | $850K | Sell |
9,787
-149
| -1% | -$13.4K | 0.01% | 688 |
|
|
2019
Q2 | $907K | Sell |
9,936
-1,231
| -11% | -$104K | 0.01% | 615 |
|
|
2019
Q1 | $962K | Sell |
11,167
-468
| -4% | -$37.6K | 0.01% | 587 |
|
|
2018
Q4 | $895K | Sell |
11,635
-1,768
| -13% | -$138K | 0.01% | 585 |
|
|
2018
Q3 | $1.03M | Sell |
13,403
-1,247
| -9% | -$92.2K | 0.01% | 608 |
|
|
2018
Q2 | $992K | Buy |
14,650
+731
| +5% | +$50.4K | 0.01% | 614 |
|
|
2018
Q1 | $1.01M | Sell |
13,919
-7,276
| -34% | -$554K | 0.01% | 611 |
|
|
2017
Q4 | $1.59M | Sell |
21,195
-992,748
| -98% | -$74.9M | 0.01% | 461 |
|
|
2017
Q3 | $78M | Sell |
1,013,943
-14,123
| -1% | -$1.07M | 0.73% | 45 |
|
|
2017
Q2 | $76.9M | Sell |
1,028,066
-46,627
| -4% | -$3.3M | 0.74% | 44 |
|
|
2017
Q1 | $71.5M | Sell |
1,074,693
-120,924
| -10% | -$8.06M | 0.67% | 50 |
|
|
2016
Q4 | $78M | Buy |
1,195,617
+4,545
| +0.4% | +$295K | 0.7% | 48 |
|
|
2016
Q3 | $84.3M | Sell |
1,191,072
-6,230
| -0.5% | -$454K | 0.78% | 47 |
|
|
2016
Q2 | $88.5M | Sell |
1,197,302
-2,602
| -0.2% | -$180K | 0.81% | 35 |
|
|
2016
Q1 | $77.9M | Sell |
1,199,904
-65,476
| -5% | -$4.45M | 0.71% | 50 |
|
|
2015
Q4 | $97.6M | Sell |
1,265,380
-30,807
| -2% | -$2.45M | 0.86% | 29 |
|
|
2015
Q3 | $107M | Sell |
1,296,187
-29,761
| -2% | -$2.65M | 0.96% | 21 |
|
|
2015
Q2 | $117M | Sell |
1,325,948
-54,187
| -4% | -$4.97M | 1.05% | 20 |
|
|
2015
Q1 | $122M | Sell |
1,380,135
-278,068
| -17% | -$24.7M | 1.09% | 23 |
|
|
2014
Q4 | $138M | Buy |
1,658,203
+865,458
| +109% | +$71.7M | 1.2% | 11 |
|
|
2014
Q3 | $66.9M | Sell |
792,745
-950,219
| -55% | -$76.9M | 0.81% | 29 |
|
|
2014
Q2 | $141M | Sell |
1,742,964
-65,495
| -4% | -$5.15M | 1.22% | 18 |
|
|
2014
Q1 | $138M | Sell |
1,808,459
-23,649
| -1% | -$1.72M | 1.17% | 19 |
|
|
2013
Q4 | $132M | Sell |
1,832,108
-11,994
| -0.7% | -$834K | 1.21% | 16 |
|
|
2013
Q3 | $127M | Buy |
1,844,102
+29,120
| +2% | +$1.93M | 1.49% | 10 |
|
|
2013
Q2 | $115M | Buy |
+1,814,982
| New | +$118M | 1.41% | 12 |
|
Other funds holding NVS
Sterling Capital Management's NVS Position: Q1 2026 in Review
Sterling Capital Management reduced its Novartis (NVS) stake by 0.01% in Q1 2026, selling an estimated $153 and leaving 13,491 shares worth $2.06M. The position accounts for 0.04% of the portfolio, ranked #330.
Sterling Capital Management first reported a position in NVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $141M in Q2 2014. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Sterling Capital Management held 13,491 shares of Novartis worth $2.06M as of Q1 2026.
- Sterling Capital Management sold 1 Novartis share in Q1 2026, an estimated $153.
- Novartis made up 0.04% of Sterling Capital Management's portfolio in Q1 2026, its #330 holding.
- Sterling Capital Management first reported a position in Novartis in Q2 2013 and has held it in 33 quarters since.
- Sterling Capital Management's Novartis position peaked at $141M in Q2 2014.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.